AMR news related to Healthy Patients

For Healthcare Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.


8 March 2023

The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021

8 March 2023

SMART researchers develop novel combination bacterium- and host-targeted therapy for treating vancomycin-resistant bacterial infections

8 March 2023

NEW TB VACCINES NEEDED TO TACKLE AMR

16 February 2023

Bacterial Antimicrobial Resistance: Data Gaps and Relationships between Human and Animal Resistance

9 February 2023

Spread of antibiotic resistance revives interest in bacteria-killing viruses

7 February 2023

Effect of Antibiotic Prescription Audit and Feedback on Antibiotic Prescribing in Primary Care

3 February 2023

Awareness of antibiotic resistance: a tool for measurement among human and animal health care professionals in LMICs and UMICs

1 February 2023

Antibacterial Nanomaterials: Mechanisms, Impacts on Antimicrobial Resistance and Design Principles

31 January 2023

Genomic reconstruction and directed interventions in a multidrug-resistant Shigellosis outbreak in Seattle, WA, USA: a genomic surveillance study

31 January 2023

Emergence of extensively drug-resistant and multidrug-resistant Shigella flexneri serotype 2a associated with sexual transmission among gay, bisexual, and other men who have sex with men, in England: a descriptive epidemiological study

31 January 2023

Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial

26 January 2023

FDA advisors back Cidara antifungal rezafungin

26 January 2023

How antidepressants help bacteria resist antibiotics

25 January 2023

EU must do more to tackle antibiotic shortages, say patient groups

24 January 2023

Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial Evaluating Phage Therapy in Cystic Fibrosis-related Respiratory Infection

19 January 2023

2 days versus 5 days of postoperative antibiotics for complex appendicitis: a pragmatic, open-label, multicentre, non-inferiority randomised trial

11 January 2023

Phage therapy: From biological mechanisms to future directions

5 January 2023

In silico discovering relationship between bacteriophages and antimicrobial resistance

5 January 2023

Association of Appropriate Empirical Antimicrobial Therapy With In-Hospital Mortality in Patients With Bloodstream Infections in the US

16 December 2022

The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline

15 December 2022

Comparison of bacterial suppression by phage cocktails, dual-receptor generalists, and coevolutionarily trained phages

12 December 2022

The WHO AWaRe (Access, Watch, Reserve) antibiotic book

9 December 2022

A need for novel diagnostics: meeting the moment

8 December 2022

IFPMA and AMR Insights enter into Partnership

5 December 2022

FDA Approves First Fecal Microbiota Product

28 November 2022

Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis

13 November 2022

Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin

8 November 2022

In situ, in vivo and in vitro approaches for studying AMR plasmid conjugation in the gut microbiome

26 October 2022

Cut animal transport times to reduce rise of superbugs, says EU agency

22 October 2022

Upstream Intervention Effective in Reducing Unnecessary Antibiotic Prescriptions

20 October 2022

NIH-supported clinical trial of phage therapy for cystic fibrosis begins

18 October 2022

One Health Joint Plan of Action launched to address health threats to humans, animals, plants and environment

11 October 2022

Perceptions and attitudes about antibiotic resistance in the general public and general practitioners in France

11 October 2022

NIH-supported clinical trial of phage therapy for cystic fibrosis begins

8 October 2022

Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial

7 October 2022

Antimicrobials and Non-healing Wounds: An Update

7 October 2022

Management of Drug-Resistant Tuberculosis in Pregnant and Peripartum People: A FIELD GUIDE

17 September 2022

Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction

3 September 2022

Antibiotic indications and appropriateness in the pediatric intensive care unit: a ten-center point prevalence study

1 September 2022

Natural virus predators offer potential alternative to antibiotics

30 August 2022

Improving Antibiotic Stewardship for Diarrheal Disease With Probability-Based Electronic Clinical Decision Support

29 June 2022

Highly antibiotic-resistant strain of MRSA that arose in pigs can jump to humans

16 June 2022

Shionogi, GARDP and CHAI announce landmark license and collaboration agreements to treat bacterial infections by expanding access to cefiderocol in 135 countries

14 June 2022

Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis

28 May 2022

Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures

27 May 2022

Fungal infections are next chapter in reporting on superbugs

24 May 2022

Report: WHO Strategic Priorities on Antimicrobial Resistance

19 May 2022

The co-occurrence of antibiotic resistance genes between dogs and their owners in families

19 May 2022

Antimicrobial Resistance in Ocular Bacteria

14 May 2022

ARGs Prevalence Among Hospitalized COVID-19 Patients with Bacterial Infections and Resistome abundance



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed